Man Group’s Nuvation Bio NUVB Stock Holding History

Man Group’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.71M	Buy	+632,238	New	+$3.52M	﹤0.01%	1432
2025 Q4	–	Sell	-89,357	Closed	-$331K	–	2403
2025 Q3	$331K	Buy	89,357 +50,744	+131%	+$138K	﹤0.01%	1973
2025 Q2	$75.3K	Buy	+38,613	New	+$80.4K	﹤0.01%	2130
2024 Q3	–	Sell	-110,626	Closed	-$323K	–	2128
2024 Q2	$323K	Sell	110,626 -149,653	-57%	-$457K	﹤0.01%	1773
2024 Q1	$947K	Buy	260,279 +21,949	+9%	+$42.1K	﹤0.01%	1561
2023 Q4	$360K	Buy	+238,330	New	+$307K	﹤0.01%	1772
2022 Q4	–	Sell	-55,100	Closed	-$123K	–	2139
2022 Q3	$123K	Buy	+55,100	New	+$157K	﹤0.01%	1839
2022 Q2	–	Sell	-14,500	Closed	-$63.2K	–	1853
2022 Q1	$76K	Buy	+14,500	New	+$81.5K	﹤0.01%	2087

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Man Group's NUVB Position: Q1 2026 in Review

Man Group opened a new position in Nuvation Bio (NUVB) in Q1 2026: 632,238 shares worth $2.71M. The stake represents ﹤0.01% of the portfolio and ranks #1432 among its holdings. This is a return to the name: Man Group previously reported a position in NUVB as recently as Q3 2025.

Man Group first reported a position in NUVB in Q1 2022 and has held it in 8 quarters since. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

Man Group held 632,238 shares of Nuvation Bio worth $2.71M as of Q1 2026.
Nuvation Bio was a new Man Group position in Q1 2026.
Nuvation Bio made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #1432 holding.
Man Group first reported a position in Nuvation Bio in Q1 2022 and has held it in 8 quarters since.
231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.